AstraZeneca Plc Chief Financial Officer Aradhana Sarin discusses the company’s financial results, outlook and strategy. Cambridge, England-based Astra raised its outlook for 2022 revenue after second-quarter sales and earnings per share exceeded analysts’ expectations, fueled by growth in all disease areas including Covid-19 medicines. Sarin speaks with Tom Mackenzie on “Bloomberg Markets: Europe.”